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Abstract
Bronchoscopy is an established research tool in Malawi, enabling collection of pulmonary
samples for immunological, pharmacological, and microbiological studies. It is, however,
an invasive clinical procedure that offers no direct benefit to volunteering participants when
used in a research capacity alone, and thus informed consent is essential. This study
aimed to explore TB patients’ understanding of research bronchoscopy, what would moti-
vate them to participate in research bronchoscopy, and their concerns, in order to inform
consenting processes for future clinical studies. We used a qualitative research design.
Two focus group discussions were conducted with community members and TB patients to
understand their perceptions of bronchoscopy. Transcripts were coded by multiple co-
authors and thematic content analysis was used to analyse main findings. We found that
Malawian patients with pulmonary TB were willing to participate in a study using research
bronchoscopy for health assessment and access to improved healthcare. We identified
information of value to potential participants when consenting to that may lessen some of
the anxieties expressed by participants. Patient and public involvement is essential to
improve informed consent and institutional trust.
Introduction
Fibreoptic bronchoscopy is well-established in routine clinical practice for diagnostic and ther-
apeutic purposes; with bronchoalveolar lavage (BAL) internationally accepted as a research
tool [1]. Our research programme in Malawi has used research bronchoscopy to collect
pulmonary samples for immunological and microbiological studies, and plans to extend its’
use to assessment of intrapulmonary pharmacology, specifically for tuberculosis (TB) drugs.
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While bronchoscopy for research purposes has previously been done in healthy adult volun-
teers and sputum smear-negative pulmonary TB suspects, there is no precedence in Malawian
adults with microbiologically-confirmedsputum smear-positive pulmonary TB. Bronchoscopy
is an invasive clinical procedure that offers no direct benefit to volunteering participants when
used in a research capacity alone. Complications are rare but include chest pain, fever, pneu-
monia, vocal cord injury, epistaxis, and extremely rarely, death, and thus informed consent is
essential [2–4]. Previous work fromMalawi suggested that the majority of bronchoscopy-expe-
rienced volunteer research participants reported that they valued the research study they were
involved in, while new volunteers expected to benefit directly from the research [2]. The main
perceived benefits were health assessment and prompt treatment if unwell, rather than remu-
neration.While most research participants felt they received adequate information before the
study, semi-structured interviews identified limited understanding of the procedure in some
participants. In order to inform the design of our future studies in TB patients, we sought to
involve potential participants in the development of our consenting process and ensure that we
addressed their concerns in advance of any procedure.
The Declaration of Helsinki outlines the ethical principles of medical research, and
enshrines the need for informed consent, freedom from coercion, and protection of patient
safety in research studies [5]. Health literacy, trust, and the quality of the interaction between
patient and provider may all positively influence the quality of the consenting process and
extent of engagement in research [6]. While written information and signed consent represent
the standard, difficulties and controversy may arise in low-income settings where low levels of
formal education, limited access to medical services and differing values and interpretation of
health and illness make the practical application of these standards challenging [7, 8]. Engaging
patients or public in research prior to study implementation is therefore seen to address their
concerns, enhance trust, and can improve informed consent, mutual learning, recruitment and
retention of research participants [9]. Patient and public involvement (PPI) is increasingly
being advocated in health research to prevent harm to participants, improve the relevance of
information sheets and the quality of informed consent [10, 11]. Boulanger (2013) however
argues that little attention has been given to community engagement or PPI in TB research and
this paper contributes to this knowledge gap [12].
We aimed to explore the needs and concerns of prospective research bronchoscopy partici-
pants, in order to inform study design, information provision, and consenting processes for
our future clinical studies. This descriptive study highlights topics of importance to partici-
pants in research bronchoscopy studies, and may inform consenting processes for other inva-
sive procedures in low-income settings.
Materials and Methods
Research team
Focus group discussions (FGDs) were facilitated by two experienced female, Malawian Social
Scientists (DN and ML). At the time of data collection,DN was a Social Science PhD candidate
and ML was a Social Science Researcher, both based at the Malawi-Liverpool-Wellcome Trust
Clinical Research Programme. Both were native Chichewa speakers. The principal investigator
(AM) is a British Infectious Diseases Physician who was planning to use bronchoscopy in a
study assessing the intrapulmonary pharmacology of TB drugs. He was present at FGDs to
answer any study- or bronchoscopy-specific enquiries, but as a non-Chichewa speaker, his role
was limited to that of an observer.
Study participants had not met the researchers prior to taking part in the FGDs. Study
researchers were not part of normal TB service provision, and participants were advised that
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taking part would not affect their current care. Participants were aware that AMwas planning
a bronchoscopy-based study of TB drugs, and that this work would be used to guide the
recruitment and consenting processes in future work.
Study design
This was a cross-sectional study of adult patients with pulmonary TB, and other members of
the community in urban Blantyre, Malawi. We used a phenomenological approach to gather
information on the perspectives and views of TB patients with regards to research bronchos-
copy studies. Two FGDs were organised with the assistance of the TB officers at Queen Eliza-
beth Central Hospital (QECH), a large district and referral hospital. The first group (FGD1)
consisted of mixed community members with some experience of TB—for example, spouses /
carers of patients. The second group (FGD2) consisted of TB patients on treatment, but living
at home and referring regularly to hospital. This enabled comparison of the perception of
research bronchoscopy between healthy lay persons and TB patients. While many of the partic-
ipants had experience of TB illness and care, none had experience of bronchoscopy. FGDs
were chosen to enable the exploration of abstract concepts and social norms in the absence of
embodied experience of bronchoscopy in these groups.
The two FGDs occurred in Ndirande, an urban settlement in Blantyre in the catchment area
for QECH, in July 2014. This site was chosen as a future recruitment location for research bron-
choscopy studies. Participants were included provided they were over 18 years old and could
give informed consent. TB patients registered and receiving treatment at Ndirande Health Cen-
tre—prospective participants to our future work—were invited to attend a FGD. Twelve partici-
pants were recruited into each group, in approximately equal numbers of men and women.
Participants were recruited by convenience sampling, reflecting the process of recruitment to
the proposed research bronchoscopy study. By interviewingmixed groups, we aimed to capture
the dynamic in the TB Registry, where mixed participants registering for TB treatment would be
recruited to a bronchoscopy-based study. Three participants in FGD2 failed to attend the FGD.
The demographics of the participants are summarised in S1 Table. All of the FGD participants
were employed and educated to a minimum of Standard Two (primary school). Twelve partici-
pants were educated to secondary level. The FGDs occurred in a community hall.
Participants were provided with an information sheet for the study in Chichewa, the native
language of the participants. After written consent to participate, the information sheet explain-
ing the proposed research bronchoscopy TB pharmacology project (S1 File) was read to the par-
ticipants in Chichewa, and they were given the opportunity to ask questions. Sections requiring
further clarification, such as the details of the bronchoscopy procedure and the difference
between research and clinical care, were explained further and the relevant sections re-read. The
content of the information sheet was refined for FGD2 based on the feedback from the first
group. A topic guide with open-ended questions was used to facilitate the FGDs (S2 Table), and
included the broad themes of understanding of research, motivation for participation in studies
of this nature, concerns, and feedback. These themes were developed through a deductive con-
ceptual framework, drawing on pre-conceptions and previous work on bronchoscopy-based
research in Malawi [2]. FGDs were recorded using a digital recorder, transcribed verbatim and
translated into English. FGDs took approximately two hours, with field notes taken during the
FGDs. Transcripts were checked for quality and accuracy by those who conducted the FGDs
Analysis
The FGD transcripts were codedmanually by AM, DN, andWL.We developed an initial cod-
ing framework based on a combination of research questions and an inductive approach to
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document emergent themes from the data. Emergent themes were triangulated throughmulti-
ple and independent coding (AM, DN &WL). The coding frameworks were compared, refined
and updated through regular meetings. Using thematic content analysis, a matrix of responses
from the FGDs was generated in Excel (Microsoft Excel 2013, Microsoft Corporation, Red-
mond, WA, United States of America). The responses from the two FGDs were compared for
similarities and differences across each theme using constant comparison approaches [13].
Direct quotations from research participants cited were chosen explicitly to represent domi-
nant themes emerging from the thematic analysis. We drew on COREQ guidelines when
reporting our findings.
Ethical approval
This study was approved by the University of Malawi, College of Medicine Research Ethics
Committee (approval number: P.05/14/1575). All participants gave written informed consent
(or a witnessed thumb print if illiterate) to take part in the study.
Results
Understanding of health research
In both FGDs, participants had difficulty distinguishing between research and a health inter-
vention. Both groups expressed a motivation to participate in this proposed project as they
expected to benefit directly from clinical assessment. For some, this was simply the benefit of
being a part of a research study with clinical input beyond that received in standard TB care.
For many participants however, they felt that the bronchoscopy would give them immediate
information about their “health status”, and an indication of how well the TB drugs were work-
ing in their body. A typical response was:
“I can join this research study because I would like them to examine me and find out how I
am inside (internally) as I am taking the drug, saying: is the drug functioning well? On the
other hand, there is a possibility that they can add more of that drug to me.”
Participant, FGD1
In FGD2, the interviewers attempted to improve the informed consent process by carefully
explaining the difference between research and clinical care, and that participation in health
research did not equate to receiving “special treatment”. The patient information sheet was
adjusted to state that participants would not benefit directly from participation in the study,
but that the results may lead to improved treatments for TB in the future. Despite these
changes, those in FGD2 still expected immediate benefit from the research in terms of
improved therapy or individual feedback on drug effectiveness.
Motivation for participation
Participants were invited to consider their motivation for participating in a research bronchos-
copy study in which they did not personally stand to benefit.Motivation was typically framed
as altruistic by participants in both FGDs, in that it may benefit future patients with TB. One
participant, an older male, gave the analogy:
Participant: “We all seem to be those people helping to build a bridge, by assisting to pass
over the materials required to construct the bridge, so that every person should what?”
All: (overlap) “they should cross properly”
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Participant: “Therefore we are not forced; it is all up to you to decide for yourself saying:
for the bridge to be complete there is need for me to go and cut down trees.”
Participant, FGD1
Some reported they had a responsibility to participate in TB research to further research
and improve care.
“. . . research is done to find an answer. Therefore, for the answer to be found quickly, there is
need for me to be with them on the same side [I need to participate in the research] so that the
research should move on well.”
Participant, FGD1
Those with TB in FGD2 discussed the burden of TB, and that by participating in research
studies such as this they could help fight to eliminate the disease.
Concerns
Fear of exploitation. Participants in FGD1 raised concerns that research may be exploit-
ative, and that safeguarding of participant’s safety may be a secondary concern. Typical
responses included:
“On the other hand they say: whenever a research is coming up, the government indicates or
even signs that it doesn’t care for those 200 or 300 people [enrolled in research], even if they
die. This is the reason why most people get discouraged saying: aah should I die (laughter), the
fears happen to be there.”
Participant, FGD1
“People say: whenever there is a research, we feel that maybe the health sector [Ministry of
Health] would like to use us to gain knowledge. Most people like to say that: aah I cannot join
a research; they would like to learn from our bodies, most people like to put it that way.”
Participant, FGD1
“When new research projects are coming in, some people say: they want to learn using our
bodies, they are the people chewing a lot of money, but when the research is happening, it is
done on us.”
Participant, FGD1
This fear of exploitation was not expressed in FGD2 –those with personal experience of TB
illness and healthcare delivery.
Fear of potential risks of research bronchoscopy. Having explained the research bron-
choscopy patient information sheet to the focus group participants, they were invited to give
their opinions on the use of bronchoscopy as a tool to investigate TB drugs. Participants were
mainly in favour of the research, though some expressed some apprehensions. Much of the
fear emerged from participants having a limited understanding of the bronchoscopy procedure
and any potential risks given the information provided. Anxieties stemmed from being unable
to visualise the bronchoscope itself, and were assuaged by inclusion of an illustration and
explanation of the size of the instrument in FGD2.
In FGD2, a number of participants sought clarification on the ‘fluids’ taken during the bron-
choscopy procedure. It became apparent that the use of BAL, or washing, was not clear, and
that participants took this process to be akin to taking blood (by venepuncture). As such, a
number of participants discussed the bronchoscope entering “small veins” within the lungs.
Participants sought clarity on the appearance and texture of the bronchoscope, concerned it
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may be the size of a “water pipe” or made up of metal. Another participant in FGD1 expressed
anxieties that the bronchoscopy procedure may adversely affect the circulation of the blood if
they draw a lot of fluid from one’s body.
We sought comments on further information of importance to potential participants. Partici-
pants requested specific detail about the duration of the intervention, and the expectedduration of
any side effects. Fever was included as a rare side effect in the patient information sheet (S1 File),
but a number of participants in FGD1 focussedon how long this side effect could be expected to
last. By including this information, they would have an idea when to be worried about the dura-
tion of side effects and seek help. Rather than deterring participants, full disclosure of risks was
appreciated. Furthermore, accurate information was important for trust of the study team.
"As for me, I feel that in that case, if I feel pain or whatsoever [side effect], the way they have
explained it, and they have counselled me that you will feel pain to this extent, if I experience
it, I will come back [for a second bronchoscopy]. But if it [the side effect] exceeds the limit
[beyond what was initially discussed]: like you said: 24 hours of pain and fever for two days,
this means that the research study is different from what you have told us.”
Participant, FGD1
Other information that would be appreciated included how long the coughmay last after
bronchoscopy, and how long the anaesthesia would be expected to last. Pain and bleeding were
rarely mentioned in the discussions, but again, duration and amount were issues that con-
cerned participants.
Views on HIV testing. Routine testing for HIV as a criterion for participant recruitment was
raised as a concern by participants in FGD1, and there was a feeling that this should be optional.
“As for me, what I feel is that most of us get troubled inside our hearts, saying: AIDS is incur-
able, therefore people become scared, that it’s better to stay without knowing your health
(HIV) status. But as for TB we know that this is curable.”
Participant, FGD1
This did not seem to be an issue with the TB group—FGD2 –presumably as HIV testing
and counselling is an established part of the TB diagnostic process and reflected their clinical
experience. This was echoed by a number of participants, who appreciated the importance of
diagnosis, even when asymptomatic, primarily for treatment reasons:
Interviewer: “. . .Is the person joining this research study supposed to undergo an HIV test?”
All: “Yes”
Interviewer: “Do you feel this is appropriate?”
All: “Yes!”
Interviewer: “Why is that so?”
Participant: “Because he/she will know about her body if he/she has TB. . .therefore you
are in a position to know whether you have TB as well as HIV. . . and you get treated for both
of these”
Participants, FGD2
Results feedback and compensation
A common concern of participants was that results should be fed back to the community, with
some commenting that they do not even know when a study is ended:
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“When the research comes to an end, they just leave and go. . . We still think that we are
enrolled in the research study not knowing that we are out.” (laughter)
Participant, FGD1
As payment for participating, information about the study’s results was considered to be a
requirement:
“. . .because I was one of those people participating in the study [research participant], there-
fore I should know the answer to the research study [research findings].”
Participant, FGD1
Other than the results of the study, an idea of how many people the study results stand to
benefit was requested, and whether any recommendations were made to improve TB treatment
by the researchers.
Some participants felt that the clinical assessment itself was a motivation and reward for
recruitment into a research bronchoscopy study, and many voiced that any adverse events or
intercurrent illnesses occurringwithin the course of such a study should be treated promptly.
Participants in FGDs with TB patients, were aware of other studies providing prompt health-
care outside the study interventions. One participant in FGD2 indicated that they felt that med-
ical care above that available in Malawi may be a suitable recompense for an adverse event, but
this opinion was not echoed by the other participants.
“For instance if a person has severe bleeding and not as expected, saying: it did not come out
the way you had expected it to come out, you must give her treatment to stop the bleeding.
They must take her to big hospitals if they feel that the problem is major, regardless of how
much it will cost. . .the researchers must take responsibility if the patient becomes severely ill
because they enrolled in the research. . .They should find treatment even if it means flying the
patient outside the country.”
Participant, FGD2
Compensation requests were modest: reimbursement for transport or a meal allowance
were the commonest suggestions. Others suggested that counselling and additional study visits
were of benefit enough to them. In FGD1, there were a number of participants who felt that the
compensation should reflect the distance travelled to the hospital, and furthermore, that con-
sideration should be given to lost earnings as a result of taking part:
“Because from a women's perspective, if you want us to be in a research study we will have to
leave our homes at the time that you have asked us to meet you. Maybe we had plans to go
and pick sweet potato leaves [for food], we failed, because we only have limited time. With the
money [compensation] given we could pass by the market and use the same money to buy
some mustard and charcoal, and cook [a meal].”
Participant, FGD1
Discussion
In this study, we explored perceptions of research bronchoscopy in a population of Malawian
adults, in order to inform the design of future clinical studies using bronchoscopy. Findings
indicate a general willingness to participate in studies of this nature, primarily for accrual of
personal benefits. Participants expected to benefit directly from clinical assessment, and had
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difficulty distinguishing between research and routine clinical care. We identified shortcom-
ings in the informed consent process that will inform clinical practice for future research bron-
choscopy-based studies. Through the FGDs, we identified information of value to potential
research participants that will guide subsequent engagement strategies.
In this group of bronchoscopy-naïve individuals, there was a common difficulty in distin-
guishing between interventions performed solely for research purposes, and standard clinical
care. Many participants expressed a wish to participate in a research bronchoscopy study for
assessment of their “health status”, and expected to receive immediate feedback on drug effi-
cacy and their response to treatment. This was particularly true in FGD1, where participants
expected individualised feedback post-bronchoscopy rather than aggregate data at study close.
This confusion has been described as ‘therapeutic misconception’ in similar research settings—
a belief that every aspect of a research project was designed to benefit the individual directly—
and raises concerns that participants may have difficulty distinguishing between investigational
research and health intervention whenmaking an informed choice [6, 14]. Rather than being a
fault of the participant, we would argue that this confusion was a shortcoming of the informed
consent process and our explanations to FGD participants.
The model of therapeutic misconception places the blame for the misunderstanding with
the study participants, and has been described as particularly problematic in resource-limited
settings due to a combination of low levels of literacy, poor education, poor access to health-
care, high disease burden, and indeed the impact of illness, suffering, poverty, and provider
roles on decisionmaking [14–16]. A meta-analysis of informed consent comprehension in
African settings reported that comprehension of key concepts was poor [15]. Understanding
the investigative or experimental nature of research is clearly a key component in collecting
true informed consent, but may be more challenging in a resource-limited setting. Firstly, care
quality in Malawi is limited by shortages of healthcare personnel and medications in Govern-
ment facilities [17]. Researchers have an ethical and moral obligation to provide healthcare to
benefit participants, and thus the appropriate provision of substantial and quality medical care
in research can result in genuine difficulty in distinguishing between healthcare and research
[6, 17]. Rather than a misconception, the provision of healthcare to study participants may pro-
vide incentive to recruitment, with participants actively choosing to enrol in research as a ratio-
nal endeavour to access better-resourced care. Secondly, the onus should be on the researcher
to properly inform potential participants of the research nature of the study, and to underscore
the assertion that there can be no guarantee of therapeutic benefit [18]. While we attempted to
emphasise the investigational nature of the research in FGD2, participants still expected to
directly benefit from bronchoscopy. This information will be used when planning our engage-
ment strategy and informed consent processes in future work.
By inviting bronchoscopy-naïve individuals to the FGDs, we aimed to capture a group simi-
lar to those that would be recruited to a future bronchoscopy-based study, and gather their
views of research bronchoscopy in the absence of embodied experience.As such, participants
were asked to consider their motivation in an abstract way. Both FGDs framed their motivation
for participation as altruistic: that it would benefit future patients with TB, or that taking part
would contribute to eliminating TB disease. This is likely to reflect a social desirability bias: a
product of the need to impress the group rather than a true individual perspective [19, 20].
When asked later to consider compensation for participation in research, participants stated
that clinical assessment was both a motivation and a reward, and that they expected to be
treated promptly in the event of adverse events or intercurrent illnesses. Furthermore, they
should stand to benefit should the study lead to improved TB treatment. Rather than altruism,
participants were motivated by eventual self-benefit, or the belief that they may lose out by
non-participation.
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Limited data from resource-poor settings exists on the motivation of individuals to partici-
pate in non-therapeutic biomedical research. In India, one study reported that healthy individ-
uals were most likely to cite financial reward as their motivation, whereas patients would
participate after being invited by their treating physician [21]. Altruism, free medical check-up,
curiosity, and personal health benefit were also cited as motivation for recruitment to non-
therapeutic trials [21]. Recently, a qualitative study from Blantyre, Malawi, identified that
ancillary care, monetary and material incentives, and more thorough medical diagnosis
encouraged participation in biomedical research [17]. While improved medical care was cited
in this study, monetary and material incentives were mentioned rarely, and when compensa-
tion was discussed, the requests of participants were relatively modest. Participants in FGD2
commented that compensation should consider lost earnings due to the time spent participat-
ing in research. These costs may not be routinely considered in study design, and risk partici-
pants being under-compensated rather than induced for their role in research [22]. Both
groups expected feedback of results at study completion as compensation for taking part.
While one FGD2 participant stated that they may never know if the study they participated in
has reached completion, care should be taken to provide community feedback because this
important in encouraging institutional trust and ensuring ethical practice. Such feedback is
already occurring at our research programme in Malawi through an existing Science Commu-
nication Department, through science cafes and community advisory groups, and researchers
should continue to be encouraged to use them. Lack of feedback from research studies is a
common complaint, even should those results be distressing [23–27]. This may simply be the
provision of study conclusions to participants, but where appropriate, any results of impor-
tance to individual participants should be fed back to enable appropriate medical care. This has
been highlighted in genetic studies, where data on future health risks may be uncovered, but
could equally be applied to incidental findings during bronchoscopy [28, 29]. Ultimately, stud-
ies should be reciprocal, and not simply extractive.
Whereas previous work fromMalawi interviewedbronchoscopy-experienced individuals
[2], we sought to assess the understanding of research bronchoscopy in bronchoscopy-naïve
participants after provision of a patient information sheet. Potential participants understand-
ably had difficulty envisioning a bronchoscope, and requested information on its’ dimensions,
appearance, and texture: information that we included for FGD2. Given that these participants
were bronchoscopy-naïve, and asked to imagine the procedure, these misconceptions reflect
shortcomings in the information provision by researchers, rather than a lack of participant
education, and highlight areas for clarification in future bronchoscopy-based research. The
FGD participants in this study were keen that the patient information sheet provided explicit
information as to the duration and severity of any side-effects in advance of the study, and the
accuracy of this information was important to fostering trust.
There are a number of limitations to this study that merit discussion. Firstly, none of these
participants had prior experience of invasive procedures such as bronchoscopy, and were
asked to consider their involvement in such research in an abstract manner. By so doing, we
hoped to understand the perceptions and concerns of a bronchoscopy-naïve population to bet-
ter reflect those individuals recruited into future projects. Secondly, the use of the FGDmethod
likely shaped the responses to some questions, particularly around motivation. Participants
will try to project a positive impression to the group, and the researchers, and should be taken
into account in the interpretation of their comments. Furthermore, by choosing to participate
in the FGDs in the first place these participants may already be biased in favour of research. It
is difficult to know how individual experiences influenced responses with this method, and
future work may consider how these responses translate into embodied experience in practice:
how many would actually enrol in a research bronchoscopy study? In later work, we will invite
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TB patients undergoing research bronchoscopy to return for semi-structured interviews and
focus group discussions to explore their experience-basedperceptions of research bronchos-
copy and the consenting process used.
Some of the study limitations were that only two FGDs were conducted, and we did not tri-
angulate findings across different sources or methods. The small sample size reflected the avail-
ability of registered patients to attend the FGDs, and was felt to be adequate for a descriptive
study to inform the design of a clinical study. We interviewedparticipants who were willing to
attend the FGD, and supplemented this by interviewing relatives and carers. Nevertheless, the
two FGDs gave diverse perspectives on bronchoscopy research and similar themes appeared in
both groups. Three authors (AM, DN andWL) were also involved in the data analysis pro-
cesses to enhance trustworthiness of our research findings.
In conclusion, we have shown that Malawian patients with pulmonary TB are willing to par-
ticipate in a study using research bronchoscopy, and would do so for health assessment and
access to improved healthcare. Clear, illustrated patient information sheets should help lessen
some of the anxieties expressed by potential participants, and engagement with the community
before and after the study is essential. This study contributes to Malawi-specific findings to
issues around ethics and informed consent for invasive procedures that will be of interest to a
wider audience.
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